Indeed, some studies found that intensive glycemic control ... and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Ray and co-workers abstracted relevant data from these ...

The mean time-weighted blood glucose values in the intensive-control group (6.4 ± 1.0 mmol/l) were significantly lower than those in the conventional-control group (8.0 ± 1.3 mmol/l; P <0.001 ...

In a randomized Belgian trial that was published in 2001 ... The following outcomes were improved significantly in the intensive-glucose-control phase compared with the baseline phase: fewer ...

5,14 The ADVANCE trial looked at patients after ... macrovascular events was significantly lower in the intensive glucose control group. 59 ACCORD, ADVANCE, and VADT also had a shorter study ...

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type 2 diabetes. Previous versions were administered via injection.

Researchers conducted a secondary analysis of data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial to evaluate the association between visit-to-visit variability in lipid ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery (AID) in adults with insulin-treated type 2 diabetes. AID significantly ...